Can Atrial Fibrillation Cause Erectile Dysfunction?

Atrial fibrillation and erectile dysfunction are linked, and the connection is stronger than most men realize. A meta-analysis pooling data from nearly 30,000 men found that those with atrial fibrillation had roughly 1.6 times the risk of developing erectile dysfunction compared to men without it, and cross-sectional studies consistently find that more than half of men with AFib report some degree of erectile trouble. The relationship runs through several channels at once, from the irregular heartbeat itself to the medications used to treat it, making it one of those medical situations where the condition and its treatment can both contribute to the same problem.

How Common Is Erectile Dysfunction Among Men With AFib

The numbers are striking. In a cross-sectional study of 129 consecutive AFib patients with an average age of 57, erectile dysfunction was present in about 57% of participants. But ED was only part of the picture: roughly 69% reported lowered sexual desire, 65% had decreased satisfaction with intercourse, and about 44% experienced difficulty with orgasm. Overall, at least one form of sexual dysfunction showed up in nearly 87% of the group.¹

A systematic review and meta-analysis confirmed that this finding is not a fluke of one dataset. The pooled estimated prevalence of ED among AFib patients was 57%, and the confidence interval was tight enough to suggest real consistency across studies.² That said, it is worth noting that the men in these studies carry a heavy burden of other cardiovascular risk factors. In the cross-sectional study, over 60% had hypertension, nearly a quarter had diabetes, and close to half had dyslipidemia. Those conditions can each independently drive ED, so the challenge has always been figuring out how much of the problem is the AFib itself and how much is the company it keeps.

A separate meta-analysis addressed this more directly by comparing ED rates in men with AFib against men without it. After pooling five studies involving about 4,100 AFib patients and roughly 25,700 controls, the presence of AFib was associated with about a 60% higher risk of ED. The researchers concluded that baseline atrial fibrillation independently raised the risk of ED up to 1.6-fold.³ That 1.6-fold increase accounts for shared risk factors, which means AFib is contributing something on its own.

How AFib Itself Disrupts Erectile Function

An erection depends on healthy blood vessels relaxing and filling with blood on demand. The chemical signal that triggers this relaxation is nitric oxide, which the inner lining of blood vessels produces. In AFib, several things go wrong with this process. The irregular atrial contractions create abnormal forces inside blood vessels, disrupting nitric oxide production. At the same time, AFib is associated with chronic low-grade inflammation and oxidative stress, both of which damage the endothelial lining that produces nitric oxide in the first place.³ The net result is that the penile arteries, which are already among the smallest in the body and therefore among the first to show the effects of vascular damage, lose their ability to dilate properly.

There is also a hemodynamic dimension. AFib reduces cardiac output because the heart chambers are not filling and emptying in their usual coordinated fashion. This means less blood flow overall, including to the pelvis. A study measuring blood flow in the legs found that patients who successfully converted back to normal sinus rhythm showed meaningful improvement in their vasodilatory reserve, meaning their blood vessels could open wider under demand. Patients who remained in AFib after the procedure showed no such improvement.⁴ This finding was measured in the calves, not the penis, but it illustrates a principle that applies throughout the body: AFib constrains the blood vessel relaxation that healthy tissues rely on during physical demand, and erections are, at their core, a vascular event.

The autonomic nervous system also plays a role. AFib disrupts the balance between the sympathetic nervous system, which constricts blood vessels and diverts blood during stress, and the parasympathetic system, which promotes relaxation and blood flow to the genitals. Men with AFib often live in a state of heightened sympathetic activation, which is the opposite of what the body needs for sexual arousal.

When the Medications Are the Problem

One of the most frustrating aspects of the AFib-ED connection is that several medications used to manage the arrhythmia can themselves cause or worsen erectile problems. This means a man who goes to his doctor for a racing heartbeat may leave with a prescription that helps his heart but quietly undermines his sexual function.

Beta-Blockers

Beta-blockers are among the most commonly prescribed drugs for controlling heart rate in AFib, and they have a well-known reputation for causing ED. A study comparing two beta-blockers in men with high blood pressure found that metoprolol significantly worsened erectile function scores within the first eight weeks of treatment, while nebivolol did not. Nebivolol actually improved some secondary sexual function scores, a difference the researchers attributed to nebivolol’s ability to boost nitric oxide production in addition to blocking beta receptors.⁵

This matters because many men on beta-blockers for AFib are never told that their choice of beta-blocker can make a real difference. If you are taking metoprolol or atenolol and noticing changes in sexual function, it is worth asking your cardiologist whether switching to nebivolol or a different drug class is an option. Not every beta-blocker carries the same sexual side-effect profile, and this is a case where the evidence supports making a change rather than just tolerating the problem.

Digoxin

Digoxin, though less commonly used than it once was, still shows up in AFib management, particularly in patients who do not respond well to other rate-control strategies. Its effects on sexual function are more insidious. A study of long-term digoxin use found that the drug significantly decreased sexual desire, erection quality, and the frequency of sexual activity compared to controls. The treated group also showed lower testosterone levels.⁶

Digoxin appears to affect erections through at least two separate pathways. Laboratory studies have shown that it directly inhibits testosterone production in testicular cells by interfering with key enzymes involved in hormone synthesis.⁷ But a separate study showed that digoxin also directly diminished penile rigidity during both visual arousal and nocturnal erection tests, without significantly changing testosterone or estrogen levels, suggesting that the drug has a local effect on penile tissue that is independent of its hormonal impact.⁸ In other words, digoxin hits from both directions: it lowers the hormonal drive for sex and it impairs the local machinery that produces erections.

Other Medications to Consider

Antiarrhythmic drugs like amiodarone and flecainide have not been studied as extensively for sexual side effects, but amiodarone in particular carries a long list of systemic effects that could plausibly contribute. Anticoagulants, which nearly all AFib patients take for stroke prevention, do not directly cause ED, but the anxiety around bleeding risk can affect sexual confidence. Diuretics, sometimes prescribed alongside rate-control drugs, have also been associated with ED in some studies of blood pressure management.

What Happens When Normal Heart Rhythm Is Restored

If AFib itself contributes to ED through impaired blood flow and vascular damage, then restoring a normal rhythm should logically help. The evidence supports this, and it is probably the most encouraging finding in this area of research.

A study of 220 AFib patients who underwent catheter ablation tracked their ED medication use and sexual satisfaction over one year. Among the roughly 83% of patients who maintained normal sinus rhythm after the procedure, about 77% reported stopping their ED medication and experiencing a clear improvement in sexual health and satisfaction. Among the patients whose AFib recurred, only about 5% reported any reduction in ED medication use. The difference between the two groups was stark and statistically overwhelming.⁹

Patients who maintained normal rhythm for more than six months after ablation were the most likely to stop ED medications, suggesting that the longer the heart stays in rhythm, the more the vascular system recovers. This fits with the earlier finding that cardioversion improved vasodilatory reserve only in patients who stayed in sinus rhythm a month later.⁴ The implication is that AFib’s contribution to ED is at least partially reversible, but the heart has to actually stay in normal rhythm for the benefit to materialize.

This does not mean that ablation is a treatment for ED, and no cardiologist would recommend it on those grounds alone. But if you are already being evaluated for ablation and ED is part of your concern, this data offers a reason for optimism. And for men being managed with rate-control drugs rather than rhythm-control strategies, it raises the question of whether pushing harder for rhythm restoration might yield benefits beyond the purely cardiac ones.

Using ED Medications Safely With AFib

Many men with AFib worry that taking a PDE5 inhibitor like sildenafil or tadalafil might be dangerous with their heart condition. The concern is understandable, since these drugs work by dilating blood vessels and lowering blood pressure to some extent. But for most AFib patients who are not taking nitrate medications, PDE5 inhibitors are considered safe and are widely prescribed. The main contraindication is concurrent use of nitrates, which can cause a dangerous drop in blood pressure. If you are on a nitrate, PDE5 inhibitors are off the table regardless of your rhythm status.

An intriguing piece of early research, currently only in animal form, has found that sildenafil may actually reduce susceptibility to AFib rather than worsening it. In a sheep model, sildenafil dramatically decreased both the likelihood and duration of induced atrial fibrillation episodes. The mean duration of AFib dropped from about 112 seconds under control conditions to roughly 3 seconds with sildenafil, and the percentage of inductions that successfully triggered AFib fell from 90% to 70%.¹⁰ This is far from proof that the same would happen in humans, and no one should take sildenafil hoping to treat their arrhythmia. But it does push back against the fear that ED drugs might make AFib worse. If anything, the early signal runs in the opposite direction.

The Psychological Burden

AFib takes a real psychological toll that compounds its physical effects on sexual function. The arrhythmia is unpredictable: episodes can strike during exertion, during rest, or during moments of emotional arousal. Many men develop a conditioned anxiety about physical activity, including sex, because they associate elevated heart rate with the unpleasant pounding or fluttering of an AFib episode. This kind of performance anxiety creates a self-reinforcing loop where the fear of an episode triggers enough sympathetic nervous system activation to interfere with the erection, which then worsens the anxiety for the next time.

Anticoagulation adds another layer. Men on blood thinners sometimes worry about injury during sex, which sounds irrational until you consider that for some men the anxiety is less about bruising and more about the general sense that their body is fragile and medically complicated. The result is a withdrawal from sexual activity that has less to do with actual physical inability and more to do with a changed sense of self. The cross-sectional study referenced earlier found that lowered sexual desire and diminished satisfaction were even more common than outright erectile failure, which suggests the psychological and motivational dimensions are at least as important as the hydraulic ones.¹

Untangling the Cause in Your Own Case

If you have AFib and are experiencing ED, the challenge is figuring out which factors are actually driving the problem for you. This is not purely academic, since different causes call for different responses. A few questions are worth working through with your doctor.

Medication timing: Did the ED start or worsen after beginning a specific drug? If you can trace the onset to starting a beta-blocker, digoxin, or antiarrhythmic, a medication switch may be the simplest fix.
Episode pattern: Is the ED worse during periods when AFib episodes are more frequent? If so, the arrhythmia itself may be the primary driver, and better rhythm control could help.
Risk factor load: Do you also have diabetes, obesity, high blood pressure, or sleep apnea? These conditions each contribute independently to ED, and treating them aggressively can improve things even if the AFib itself continues.
Psychological factors: Is the problem more about desire and avoidance than about the physical ability to get an erection? If morning erections are still happening but partnered sex is the challenge, anxiety or depression related to the heart condition may be the bigger issue.

Many men find that multiple factors are contributing at once, which is why the fix is rarely a single intervention. A cardiologist who is aware of the ED can often adjust the treatment approach in small but meaningful ways, whether that means switching from metoprolol to nebivolol, reconsidering rate control versus rhythm control, or simply giving clear reassurance that PDE5 inhibitors are safe for you to take.

Shared Risk Factors That Amplify Both Conditions

AFib and ED share an overlapping web of risk factors, which is part of why they co-occur so often and why treating one without addressing the other can feel like chasing symptoms. Hypertension damages blood vessels throughout the body and is present in the majority of AFib patients. Obesity promotes inflammation, raises estrogen levels in men, and mechanically strains the heart. Diabetes accelerates endothelial damage. Sleep apnea, which is remarkably common in AFib patients, independently contributes to both conditions through intermittent oxygen drops and sympathetic nervous system activation during sleep.

This overlap creates a clinical situation where aggressive management of the underlying metabolic and vascular risk factors can improve both the heart rhythm and sexual function simultaneously. Weight loss, for example, has been shown to reduce AFib episode burden and is also one of the most reliable non-pharmaceutical interventions for ED. Regular aerobic exercise improves endothelial function and helps rebalance the autonomic nervous system, addressing the underlying vascular dysfunction that links the two conditions. Treating sleep apnea, if present, can yield surprisingly broad improvements because it addresses a shared upstream cause rather than a downstream symptom.

The tendency in clinical practice is to treat AFib in the cardiology office and ED in the urology office, with neither specialist fully addressing the other’s territory. If you find yourself in this situation, it helps to be direct with both doctors about both conditions. The evidence increasingly points to AFib and ED as two manifestations of the same vascular and inflammatory processes rather than two separate diseases that happen to coexist.